BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21724534)

  • 1. The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology.
    Karkanaki A; Vosnakis C; Panidis D
    Hormones (Athens); 2011; 10(2):95-103. PubMed ID: 21724534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the measurement of anti-Müllerian hormone essential?
    Usta T; Oral E
    Curr Opin Obstet Gynecol; 2012 Jun; 24(3):151-7. PubMed ID: 22487725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
    Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
    La Marca A; Volpe A
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
    Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
    J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone in women with polycystic ovary syndrome.
    Pehlivanov BK; Orbetzova MM
    Folia Med (Plovdiv); 2011; 53(1):5-10. PubMed ID: 21644399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
    Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
    Yu M; Deng CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian Hormone in Female Reproduction.
    di Clemente N; Racine C; Pierre A; Taieb J
    Endocr Rev; 2021 Nov; 42(6):753-782. PubMed ID: 33851994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone and ovarian dysfunction.
    Broekmans FJ; Visser JA; Laven JS; Broer SL; Themmen AP; Fauser BC
    Trends Endocrinol Metab; 2008 Nov; 19(9):340-7. PubMed ID: 18805020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Shen invigorating and Chong-channel regulating method on anti-Müllerian hormone and oocyte quality in polycystic ovarian syndrome patients].
    Lian F; Zhao S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):9-12. PubMed ID: 22500381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of anti-Müllerian hormone in two rat models of polycystic ovary syndrome.
    Du DF; Li XL; Zheng SH
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1761-1767. PubMed ID: 27718294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF; Li XL; Fang F; Du MR
    Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin.
    Liu XY; Yang YJ; Tang CL; Wang K; Chen JJ; Teng XM; Ruan YC; Yang JZ
    Fertil Steril; 2019 Jan; 111(1):157-167. PubMed ID: 30477916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone and polycystic ovary syndrome.
    Łebkowska A; Kowalska I
    Endokrynol Pol; 2017; 68(1):74-78. PubMed ID: 27918066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.